Milestones in liver disease: Scoring chronic hepatitis

Journal of Hepatology

Volumn 38, Issue 4, 2003, Pages 382-386

  Desmet, Valeer J ^a  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; CATECHIN; HEPATITIS B(E) ANTIGEN; INTERFERON; LAMIVUDINE;

CHRONIC HEPATITIS; CLINICAL RESEARCH; COMPUTER ASSISTED DIAGNOSIS; CORRELATION FUNCTION; DELTA AGENT HEPATITIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DISEASE ACTIVITY; DISEASE CLASSIFICATION; DISEASE COURSE; DISEASE SEVERITY; GENOTYPE; HEPATITIS B; HEPATITIS C; HEPATITIS C VIRUS; HISTOLOGY; HISTOPATHOLOGY; HUMAN; IMAGE ANALYSIS; LIVER BIOPSY; LIVER CELL DAMAGE; LIVER CIRCULATION; LIVER FAILURE; LIVER FIBROSIS; LIVER HISTOLOGY; LIVER NECROSIS; MEDICAL ASSESSMENT; NEEDLE BIOPSY; NOTE; PATHOLOGIST; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; REPRODUCIBILITY; SCORING SYSTEM; STATISTICAL ANALYSIS; STEM CELL; TISSUE SECTION; BIOPSY; METHODOLOGY; PATHOLOGY;

BIOPSY; HEPATITIS, CHRONIC; HUMANS;

EID: 0037383894     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(03)00005-9     Document Type: Note

References (46)

1. Knodell RG, Ishak KG, Black WC, Chen TS, Craig R, Kaplowitz N, Kiernan TW, Wollman J. Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology 1981;1:431-435.
2. De Groote J, Desmet VJ, Gedigk P, Korb G, Popper H, Poulsen H, et al. A classification of chronic hepatitis. Lancet 1968;II:626-628.
3. Knodell RG, Conrad ME, Ishak KG. Development of chronic liver disease after acute non-A, non-B posttransfusion hepatitis. Gastroenterology 1977;72:902-909.
4. Gazzard BG, Portmann B, Murray-Lyon IM, Williams R. Causes of death in fulminant hepatic failure and relationship to quantitative histological assessment of parenchymal damage. Q J Med 1975;176:615-626.
5. Demeulenaere F, Desmet VJ, Dupont E, Fiasse R, Gisselbrecht H, Heully F, et al. Effets du (+)-cyanidanol-3 dans le traitement de l'hépatite chronique active. Gastroenterol Clin Biol 1981;5:314-323.
6. International Working Party. Terminology of chronic hepatitis, hepatic allograft rejection, and nodular lesions of the liver: summary of recommendations developed by an international working party, supported by the World Congresses of Gastroenterology, Los Angeles, 1994. Am J Gastroenterol 1994;89:S177-S181.
7. Desmet VJ, Gerber M, Hoofnagle JH, Manns M, Scheuer PJ. Classification of chronic hepatitis: diagnosis, grading and staging. Hepatology 1994;19:1513-1520.
8. Scheuer PJ. Scoring of liver biopsies: are we doing it right? Eur J Gastroenterol Hepatol 1996;8:1141-1143.
9. Scheuer PJ. Chronic hepatitis: what is activity and how should it be assessed? Histopathology 1997;30:103-105.
10. Ishak K, Baptista A, Bianchi L, Callea F, De Groote J, Gudat F, et al. Histological grading and staging of chronic hepatitis. J Hepatol 1995;22:696-699.
11. Hübscher SG. Histological grading and staging in chronic hepatitis: clinical applications and problems. J Hepatol 1998;29:1015-1022.
12. Desmet VJ. Immunopathology of chronic viral hepatitis. Hepatogastroenterology 1991;38:14-21.
13. Chevallier M, Guerret S, Chossegros P, Gerard F, Grimaud JA. A histological semiquantitative scoring system for evaluation of hepatic fibrosis in needle liver biopsy specimens: comparison with morphometric studies. Hepatology 1994;20:349-355.
14. Bedossa P, Bioulac-Sage P, Callard P, Chevallier M, Degott C, Deugnier Y, et al. Intraobserver and interobserver variations in liver biopsy interpretation in patients with chronic hepatitis C. Hepatology 1994;20:15-20.
15. Goldin RD, Goldin JG, Burt AD, Dhillon PA, Hubscher S, Wyatt J, Patel N. Intra-observer and inter-observer variation in the histopathological assessment of chronic viral hepatitis. J Hepatol 1996;25:649-654.
16. Hunt N, Fleming K. Reproducibility of liver biopsy grading and staging. Liver 1999;19:169-170.
17. Scheuer PJ. Classification of chronic viral hepatitis: a need for reassessment. J Hepatol 1991;13:372-374.
18. Bedossa P, Poynard T, METAVIR Cooperative Study Group. An algorithm for the grading of activity in chronic hepatitis C. Hepatology 1996;24:289-293.
19. Ludwig J. The nomenclature of chronic active hepatitis: an obituary. Gastroenterology 1993;105:274-278.
20. Batts KP, Ludwig J. Chronic hepatitis. An update on terminology and reporting. Am J Surg Pathol 1995;19:1409-1417.
21. Goodman ZD, Ishak KG. Histopathology of hepatitis C virus infection. Semin Liver Dis 1995;15:70-81.
22. Ichida F, Tsuji T, Omata M, Ichida T, Inoue K, Kamimura T, et al. Classification report. New Inuyama Classification: new criteria for histological assessment of chronic hepatitis. Int Hepatol Commun 1996;6:112-119.
23. Bianchi L, Gudat F. Chronic hepatitis. In: MacSween RNM, Anthony PP, Scheuer PJ, Portmann B, Burt AD, editors. Pathology of the liver, 3rd ed. Edinburgh: Churchill Livingstone, 1994. pp. 349-395.
24. Dioguardi N, Grizzi F, Bossi P, Roncalli M. Fractal and spectral dimension analysis of liver fibrosis in needle biopsy specimens. Anal Quant Cytol Histol 1999;21:262-266.
25. Westin J, Lagging LM, Westjal R, Norkrans G, Dhillon P. Interobserver study of liver histopathology using the Ishak score in patients with chronic hepatitis C virus infection. Liver 1999;19:183-187.
26. Hall PdlM. Broadsheet number 47: Chronic hepatitis: an update with guidelines for histopathological assessment of liver biopsies. Pathology 1998;30:369-380.
27. Brunt EM. Grading and staging the histopathological lesions of chronic hepatitis: the Knodell Histology Activity Index and beyond. Hepatology 2000;31:241-246.
28. Scheuer PJ, Standish RA, Dhillon AP. Scoring of chronic hepatitis. Clin Liver Dis 2002;6:335-347.
29. Theodossi A, Skene AM, Portmann B, Knill-Jones RP, Patrick RS, Tate RA, et al. Observer variation in assessment of liver biopsies including analysis by kappa statistics. Gastroenterology 1980;79:232-241.
30. Silcocks P. Some issues in observer error studies in pathology [Editorial]. J Pathol 1992;168:255-256.
31. Svanholm H, Starklint H, Gundersen HJ, Fabricius J, Barlebo H, Olsen S. Reproducibility of histomorphologic diagnoses with special reference to the kappa statistics. APMIS 1989;97:689-698.
32. Morris JA. Information and observer disagreement in histopathology. Histopathology 1994;25:123-128.
33. Colloredo G, Sonzogni A, Leandro G, Di Marco M, Inversi F. Impact of the size of liver biopsy on the assessment of necroinflammatory grading and fibrosis staging in chronic viral hepatitis [abstract]. J Hepatol 2001;34(Suppl 1):139.
34. Puchtler H, Meloan SN, Waldrop FS. Are picro-dye reactions for collagens quantitative? Chemical and histochemical considerations. Histochemistry 1988;88:243-256.
35. Dusheiko GM. New treatments for chronic viral hepatitis B and C. Baillière's Clin Gastroenterol 1996;10:299-333.
36. Perillo RP, Lai CL, Liaw YF, Dienstag JL, Schiff ER, Schalm SW, et al. Predictors of HBeAg loss after lamivudine treatment for chronic hepatitis B. Hepatology 2002;36:186-194.
37. Booth JCL, Foster GR, Levine T, Thomas HC, Goldin RD. The relationship of histology to genotype in chronic HCV infection. Liver 1997;17:144-151.
38. Poynard T, Ratziu V, Charlotte F, Goodman Z, McHutchison J, Albrecht J. Rates and risk factors of liver fibrosis progression in patients with chronic hepatitis C. J Hepatol 2001;34:730-739.
39. Poynard T, McHutchison J, Davis GL, Esteban-Mur R, Goodman Z, Bedossa P, Albrecht J. Impact of interferon alpha-2b and ribavirin on progression of liver fibrosis in patients with chronic hepatitis C. Hepatology 2000;32:1131-1137.
40. Poynard T, Ratziu V, Benhamou Y, Di Martino V, Bedossa P, Opolon P. Fibrosis in patients with chronic hepatitis C: detection and significance. Semin Liver Dis 2000;20:47-55.
41. Lagging LM, Westin J, Svensson E, Aires N, Dhillon AP, Lindh M, et al. Progression of fibrosis in untreated patients with hepatitis C virus infection. Liver 2002;22:136-144.
42. Khakoo SI, Soni PN, Savage K, Brown D, Dhillon AP, Poulter LW, Dusheiko GM. Lymphocyte and macrophage phenotypes in chronic hepatitis C infection. Correlation with disease activity. Am J Pathol 1997;150:963-970.
43. Kweon YO, Goodman ZD, Dienstag JL, Schiff ER, Brown RA, Burkhardt E, et al. Decreasing fibrogenesis: an immunohistochemical study of paired liver biopsies following lamivudine therapy for chronic hepatitis B. J Hepatol 2001;35:749-755.
44. Libbrecht L, Desmet V, Van Damme B, Roskams T. Deep intralobular extension of human hepatic 'progenitor cells' correlates with parenchymal inflammation in chronic viral hepatitis: can 'progenitor cells' migrate? J Pathol 2000;192:373-378.
45. Masseroli M, Caballero T, O'Valle F, Del Moral RMG, Perez-Milena A, Del Moral RG. Automatic quantification of liver fibrosis: design and validation of a new image analysis method: comparison with semiquantitative indexes of fibrosis. J Hepatol 2000;32:453-464.
46. Caballero T, Perez-Milena A, Masseroli M, O'Valle F, Salmeron FJ, Del Moral RMG, Sanchez-Salgado G. Liver fibrosis assessment with semiquantitative indexes and image analysis quantification in sustained-responder and non-responder interferon-treated patients with chronic hepatitis C. J Hepatol 2001;34:740-747.